ADARx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
ADARx Pharmaceuticals raised $446.3 million in an upsized US initial public offering, pricing 26.3 million shares at $17 each, the top end of its marketed range. The San Diego-based biotech had initially planned to...
Bayer’s Monsanto Seeks Court Approval for $7.25 Billion Roundup Settlement
Bayer’s Monsanto unit is set to appear before a Missouri state court on Monday seeking final approval of a proposed $7.25 billion settlement aimed at resolving tens of thousands of U.S. lawsuits alleging that...
GSK to Invest £400 Million in UK R&D Expansion
British pharmaceutical company GSK announced a £400 million investment over the next three years to strengthen its UK operations, including relocating its research and development activities to a new Cambridge facility. The move is...
Novo Nordisk Cuts Wegovy Prices with New Subscription Plan to Boost U.S. Access
Novo Nordisk has introduced a discounted subscription plan for its blockbuster obesity drug Wegovy in the United States, aiming to expand access for patients paying out of pocket and regain momentum against rival Eli...